We observed that sensitized tumor cells fail to recruit sufficient levels of pro-survival checkpoint kinases TBK1 and IKKε to Complex I, resulting in the loss of inhibitory Ser25 phosphorylation and an increase in activating Ser166 phosphorylation on RIPK1. The gene discussed is RIPK1; the disease is neoplasm.